Daniele Santini

Pubblicazioni

Titolo Pubblicato in Anno
CK7 and consensus molecular subtypes as major prognosticators in (V600E)BRAF mutated metastatic colorectal cancer BRITISH JOURNAL OF CANCER 2019
Inflammatory Biomarkers as Predictors of Response to Immunotherapy in Urological Tumors JOURNAL OF ONCOLOGY 2019
Percutaneous management of bone metastases: state of the art, interventional strategies and joint position statement of the Italian College of MSK Radiology (ICoMSKR) and the Italian College of Interventional Radiology (ICIR) LA RADIOLOGIA MEDICA 2019
Metronomic chemotherapy for advanced breast cancer patients in the real world practice: Final results of the VICTOR-6 study THE BREAST 2019
Role and relevance of quality indicators in the selection of first-line treatment of patients with metastatic renal cell carcinoma: a position paper of the MeetURO Group FUTURE ONCOLOGY 2019
Testosterone levels and androgen receptor copy number variations in castration-resistant prostate cancer treated with abiraterone or enzalutamide THE PROSTATE 2019
CAR-T cell therapy: a potential new strategy against prostate cancer JOURNAL FOR IMMUNOTHERAPY OF CANCER 2019
Prediction of survival with second-line therapy in biliary tract cancer: Actualisation of the AGEO CT2BIL cohort and European multicentre validations EUROPEAN JOURNAL OF CANCER 2019
Cabozantinib and apixaban: an hitherto unreported interaction JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY 2019
Skeletal Metastases of Unknown Primary: Biological Landscape and Clinical Overview CANCERS 2019
Syndrome of inappropriate anti-diuretic hormone secretion in cancer patients: results of the first multicenter Italian study THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY 2019
Use of Cardioprotective Dexrazoxane Is Associated with Increased Myelotoxicity in Anthracycline-Treated Soft-Tissue Sarcoma Patients CHEMOTHERAPY 2019
A new bioinformatic pipeline allows the design of small, targeted gene panels for efficient TMB estimation ANNALS OF ONCOLOGY 2019
The prognostic and predictive role of hyponatremia in patients with advanced non-small cell lung cancer (NSCLC) with bone metastases SUPPORTIVE CARE IN CANCER 2019
Polymorphic Variants in NR1I3 and UGT2B7 Predict Taxane Neurotoxicity and Have Prognostic Relevance in Patients With Breast Cancer: A Case-Control Study CLINICAL PHARMACOLOGY & THERAPEUTICS 2019
How do skeletal morbidity rate and special toxicities affect 12-week versus 4-week schedule zoledronic acid efficacy? A systematic review and a meta-analysis of randomized trials CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY 2019
Denosumab for bone health in prostate and breast cancer patients receiving endocrine therapy? A systematic review and a meta-analysis of randomized trials JOURNAL OF BONE ONCOLOGY 2019
New frontiers in the medical management of gastrointestinal stromal tumours THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY 2019
The Italian Rare Pancreatic Exocrine Cancer Initiative TUMORI 2019
Rechallenge for Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer With Acquired Resistance to First-line Cetuximab and Irinotecan A Phase 2 Single-Arm Clinical Trial JAMA ONCOLOGY 2019

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma